Clinical Trial Update: HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]

View source ↗

Summary

Phase 3 trial update for HSK7653 in adults with type 2 diabetes not adequately controlled by diet and exercise.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HSK7653

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED